(Q38316900)

English

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial

scientific article

Statements

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial (English)
0 references
0 references
0 references
Steven M Opal
Pierre-Francois Laterre
Bruno Francois
Steven P LaRosa
Xavier Wittebole
Thierry Dugernier
Dominique Perrotin
Mark Tidswell
Luis Jauregui
Kenneth Krell
Jan Pachl
Takeshi Takahashi
Claus Peckelsen
Edward Cordasco
Chia-Sheng Chang
Sandra Oeyen
Naoki Aikawa
Tatsuya Maruyama
Roland Schein
Andre C Kalil
Marc Van Nuffelen
Melvyn Lynn
Daniel P Rossignol
Jogadish Gogate
Mary B Roberts
Janice L Wheeler
ACCESS Study Group
1 March 2013
1154-1162

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit